| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHS1900081 | 非那雄胺片 | finasteride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-07-22 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-07-20 | view |
| JXHS1900082 | 非那雄胺片 | finasteride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-07-22 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-07-20 | view |
| JYHS1900004 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JYHS1900002 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JYHS1900001 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JXHL1300459 | 阿托伐他汀钙 | atorvastatin calcium | Active ingredient | Chemical Drugs | Import Drug Application | 2013-12-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2017-07-21 | view |
| JXHS2000029 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-04-07 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-04-04 | view |
| JXHS2000030 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-04-07 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-04-04 | view |
| JXHS1900172 | 达伐吡啶缓释片 | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-01-06 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-01-04 | view | |
| JXHR1500014 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | State Standards | 2016-01-05 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2017-01-25 | view |
| JXHL1200044 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | Import Drug Application | 2012-02-20 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2015-11-20 | view |
| JXHL1200046 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | Import Drug Application | 2012-02-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2015-11-20 | view |
| JXHR1500015 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | State Standards | 2016-01-05 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2017-01-25 | view |
| JXHL1200045 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | Import Drug Application | 2012-02-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2015-11-20 | view |
| JXHR1500013 | 草酸艾司西酞普兰片 | escitalopram oxalate | Tablet | Chemical Drugs | State Standards | 2016-01-05 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2017-01-25 | view |
| JXHS1900085 | 苯磺酸氨氯地平片 | amlodipine besylate | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-07-22 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-07-20 | view |
| JXHS1900084 | 苯磺酸氨氯地平片 | amlodipine besylate | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-07-22 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-07-20 | view |
| JYHS2100001 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-01-06 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-01-05 | view |
| JYHS2000035 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-10-11 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-10-09 | view |
| JYHS2000034 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-10-11 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-10-09 | view |